Return to Search

Journal Article

Paper title
Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling  
Short Ref
Artemether-lumefantrine (AL) is the most widely-recommended treatment for uncomplicated Plasmodium falciparum malaria worldwide. Its safety and efficacy have been extensively demonstrated in clinical trials; however, its performance in routine health care settings, where adherence to drug treatment is unsupervised and therefore may be suboptimal, is less well characterised. Here we develop a within-host modelling framework for estimating the effects of sub-optimal adherence to AL treatment on clinical outcomes in malaria patients. Our model incorporates data on the human immune response to the parasite, and AL’s pharmacokinetic and pharmacodynamic properties. Utilising individual-level data of adherence to AL in 482 Tanzanian patients as input for our model predicted higher rates of treatment failure than were obtained when adherence was optimal (9% compared to 4%). Our model estimates that the impact of imperfect adherence was worst in children, highlighting the importance of advice to caregivers.  
Electronic Publication Date

Datasets and documentation

(66.14K) Blisterpack Recorded data for PLoS One paper impact2_adherence_blisterpack_times.csv CCBY
(195.56K) Blisterpack dataset dictionary impact2_adherence_blisterpack_data_dictionary.pdf CCBY
Please note: There is a slight glitch in our system that we are trying to rectify. Any ZIP files downloaded from this site will not open directly in Windows. If you use 7Zip or similar software they will open normally. This note will be removed when the error has been identified and removed.